Shareholder sues Anson Funds over alleged $165.9M in short-swing profits

Shareholder sues Anson Funds over alleged $165.9M in short-swing profits
The hedge fund group allegedly held a financing 'vice grip' over the company
NOV 18, 2026

A shareholder lawsuit alleges a hedge fund group pocketed up to $165.9 million in illegal short-swing profits from a struggling biotech.

The complaint, filed November 16 in the US District Court for the Southern District of New York, claims Anson Funds - a hedge fund complex based in Dallas and Toronto - used its position as the dominant financier for Nasdaq-listed SELLAS Life Sciences Group to earn massive trading profits while the company was repeatedly disclosing it might not survive as a going concern.

Shareholder Andrew E. Roth brought the case on behalf of SELLAS under Section 16(b) of the Securities Exchange Act of 1934. The filing seeks disgorgement of profits "presently estimated to be not less than $54,749,932.28 and up to $165,907,405.23."

Section 16(b) is the federal rule that forces company insiders - including any shareholder owning more than 10% of a company's stock - to return profits from paired buy-sell trades made within a six-month window. It exists to stop insiders from cashing in on information advantages.

According to the filing, the Anson fund entities executed five equity financing transactions with SELLAS between March 15, 2024 and October 24, 2025. Through those deals, the funds allegedly acquired common stock and warrants representing approximately 122.1 million shares - roughly 60.5% of the company's outstanding common stock as of June 30, 2026 - and sold approximately 117.6 million of those shares into the open market.

Each deal allegedly locked SELLAS into covenants preventing it from raising equity from other investors for specified periods. The complaint describes this as a "vice grip" on SELLAS's ability to raise capital, noting the company disclosed "substantial doubt" about its ability to continue as a going concern across five consecutive quarterly reporting periods.

The warrants included "blocker" provisions - contractual caps designed to keep the funds' ownership below 4.99% or 9.99% of outstanding shares on paper. The complaint alleges these blockers only limited when the funds could exercise their warrants, not how much of the company they actually owned under SEC rules. The filing argues the funds acquired the warrants with "the purpose or effect of changing or influencing the control of" SELLAS, which under SEC Rule 13d-3(d)(1)(i) would make them beneficial owners of all underlying shares - well above the 10% insider threshold.

Several factors support that argument, according to the complaint. The funds acted as the sole or 50% source of every equity financing during the relevant period. Restrictive covenants combined with accumulated unexercised warrants allegedly blocked SELLAS from approaching other investors. The funds' beneficial ownership reached as high as approximately 49.3% of outstanding common stock after the third transaction.

The warrants also gave the funds an option to receive a premium payout - calculated using the Black-Scholes pricing model - for all unexercised warrants in any change-of-control scenario such as a merger or asset sale, "without regard to" the blocker limitation. The complaint alleges this provision "effectively gave the Anson Funds veto power over a change of control transaction."

The filing points to the funds' broader activist track record. The complaint notes the funds' website describes "Activism" as a defined strategy component - specifically, "formal engagement advocating for enhanced governance, operational and strategic changes to unlock value." The filing references recent activist campaigns involving Match Group Inc., Five9 Inc., and SPS Commerce Inc.

None of the company's SEC filings reporting the five transactions identified the funds by name, the complaint states. In one case, the filing says SELLAS described the investor only as a "single healthcare-focused institutional investor" - a characterization the complaint calls "a misleading description" that "served to obscure the identity" of the funds. The complaint alleges the fund entities filed a short-form ownership disclosure - the Schedule 13G, reserved for passive investors - when they should have filed the fuller Schedule 13D required of investors with a control purpose.

The complaint identifies two sets of alleged short-swing transactions. The first, tied to inducement warrants issued in September and October 2025, alleges profits ranging from $51,837,237.82 to $138,368,621.00. The second, tied to a January 2025 registered direct offering, alleges profits ranging from $2,912,694.46 to $27,538,784.23.

The plaintiff demanded on July 20, 2026, that SELLAS's board bring suit. The company's counsel responded on September 17, 2026, advising the board found "no basis to pursue the claims," according to the filing. More than sixty days passed after the demand, which triggered the shareholder's right to sue under Section 16(b).

The allegations in this complaint have not been tested, and no court has ruled on the claims.

Related Topics:
Clients sue Arkadios Wealth, allege firm sat on advisor’s red flags Investor accuses Pentwater of manipulating Avis stock in short squeeze

Latest News

RIA moves: Summit, UWP deals keep founders in charge; SagePoint adds RISE
RIA moves: Summit, UWP deals keep founders in charge; SagePoint adds RISE

Independent advisors in Colorado, Texas and Arkansas join larger wealth management platforms through acquisitions and partnerships

SEC censures Pacific West sales agent but declines industry bar
SEC censures Pacific West sales agent but declines industry bar

The enforcement division wanted a full bar - the Commission went lighter

CW Advisors buys $920M Woburn RIA, its seventh deal under Osaic
CW Advisors buys $920M Woburn RIA, its seventh deal under Osaic

Welch brothers’ 93 Financial Group gives the Osaic-owned RIA a fifth greater Boston office, days after a $1.6B triple acquisition

Foundation Source clients top $1.5B in grants as philanthropic giving surges
Foundation Source clients top $1.5B in grants as philanthropic giving surges

New wealth, evolving donor expectations, and responsible AI are reshaping charitable planning for advisors.

Schwab, LPL, and Fidelity veterans launch AI firm for wealth executives
Schwab, LPL, and Fidelity veterans launch AI firm for wealth executives

Bridge Operating Partners debuts with deep industry pedigree and a proprietary AI system designed to sharpen decision-making for wealth firm executives.

SPONSORED The new retirement challenge: Preparing for a longer future

Advisors are broadening the conversation beyond savings to help clients prepare for the realities of longer lives

SPONSORED Best Practices for Engaging Women Around Alternatives

Growing wealth, evolving priorities, and untapped opportunities are reshaping how women approach long-term investing.